Chaperoning the <i>Mononegavirales</i>: Current Knowledge and Future Directions

The order <i>Mononegavirales</i> harbors numerous viruses of significant relevance to human health, including both established and emerging infections. Currently, vaccines are only available for a small subset of these viruses, and antiviral therapies remain limited. Being obligate cellu...

Full description

Bibliographic Details
Main Authors: Victor Latorre, Florian Mattenberger, Ron Geller
Format: Article
Language:English
Published: MDPI AG 2018-12-01
Series:Viruses
Subjects:
CCT
Online Access:https://www.mdpi.com/1999-4915/10/12/699
Description
Summary:The order <i>Mononegavirales</i> harbors numerous viruses of significant relevance to human health, including both established and emerging infections. Currently, vaccines are only available for a small subset of these viruses, and antiviral therapies remain limited. Being obligate cellular parasites, viruses must utilize the cellular machinery for their replication and spread. Therefore, targeting cellular pathways used by viruses can provide novel therapeutic approaches. One of the key challenges confronted by both hosts and viruses alike is the successful folding and maturation of proteins. In cells, this task is faced by cellular molecular chaperones, a group of conserved and abundant proteins that oversee protein folding and help maintain protein homeostasis. In this review, we summarize the current knowledge of how the <i>Mononegavirales</i> interact with cellular chaperones, highlight key gaps in our knowledge, and discuss the potential of chaperone inhibitors as antivirals.
ISSN:1999-4915